Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$2.88B |
| 2 |
British American Tobacco
BTI
|
+$746M |
| 3 |
Becton Dickinson
BDX
|
+$691M |
| 4 |
Baker Hughes
BKR
|
+$650M |
| 5 |
CELG
Celgene Corp
CELG
|
+$646M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$2.75B |
| 2 |
Apple
AAPL
|
+$1.81B |
| 3 |
BHI
Baker Hughes
BHI
|
+$1.26B |
| 4 |
Medtronic
MDT
|
+$1.25B |
| 5 |
Charter Communications
CHTR
|
+$1.11B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.6% |
| 2 | Technology | 16.57% |
| 3 | Healthcare | 14.29% |
| 4 | Communication Services | 11.09% |
| 5 | Consumer Discretionary | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Intellia Therapeutics
NTLA
$1.49B
| $79.8M | 0.01% |
3,211,264
-15,568
| -0.5% | -$293K |
|
1077
Alaska Air
ALK
$5.29B
| $79.5M | 0.01% |
1,041,978
-341,815
| -25% | -$27.9M |
|
1078
WEX
WEX
$6.37B
| $79.1M | 0.01% |
705,177
-523,100
| -43% | -$56.7M |
|
1079
Madison Square Garden
MSGS
$9.48B
| $79M | 0.01% |
517,220
+11,373
| +2% | +$1.72M |
|
|
GNMK
1080
DELISTED
GenMark Diagnostics, Inc
GNMK
| $79M | 0.01% |
8,200,112
+179,610
| +2% | +$1.87M |
|
|
FCE.A
1081
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $78.8M | 0.01% |
3,088,677
-1,254,055
| -29% | -$30.7M |
|
1082
iShares US Financials ETF
IYF
$4.67B
| $78.7M | 0.01% |
1,403,550
-51,970
| -4% | -$2.83M |
|
|
PDS
1083
Precision Drilling
PDS
$999M
| $78.6M | 0.01% |
1,264,422
+434,269
| +52% | +$25.2M |
|
|
RICE
1084
DELISTED
Rice Energy Inc.
RICE
| $78.6M | 0.01% |
2,714,628
-152,270
| -5% | -$4.16M |
|
|
JUNO
1085
DELISTED
Juno Therapeutics, Inc.
JUNO
| $78.5M | 0.01% |
1,749,038
-37,900
| -2% | -$1.29M |
|
1086
Rexford Industrial Realty
REXR
$8.42B
| $78.4M | 0.01% |
+2,741,061
| New | +$78.6M |
|
|
ANTX
1087
DELISTED
Anthem, Inc.
ANTX
| $78.4M | 0.01% |
1,498,408
+29,900
| +2% | +$1.56M |
|
1088
Middleby
MIDD
$6.04B
| $78M | 0.01% |
608,302
+25,764
| +4% | +$3.18M |
|
1089
Nasdaq
NDAQ
$52.7B
| $77.2M | 0.01% |
2,985,936
+2,200,908
| +280% | +$54.7M |
|
1090
iShares Europe ETF
IEV
$1.67B
| $77.2M | 0.01% |
1,646,327
-3,871,792
| -70% | -$176M |
|
|
TMUSP
1091
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
| $76.9M | 0.01% |
770,685
-243,050
| -24% | -$24.7M |
|
1092
Teekay
TK
$1.01B
| $76.9M | 0.01% |
8,606,106
-93
| -0% | -$814 |
|
|
IMMU
1093
DELISTED
Immunomedics Inc
IMMU
| $76.8M | 0.01% |
5,496,851
| – | – |
|
1094
Illumina
ILMN
$31B
| $76.8M | 0.01% |
396,436
+6,762
| +2% | +$1.26M |
|
1095
Silicon Motion
SIMO
$8.6B
| $76.8M | 0.01% |
1,598,661
+1,121,265
| +235% | +$49.7M |
|
1096
Pediatrix Medical
MD
$2.18B
| $76.7M | 0.01% |
1,779,199
-1,283,344
| -42% | -$61M |
|
1097
AnaptysBio
ANAB
$1.58B
| $76.6M | 0.01% |
+2,192,030
| New | +$59.1M |
|
1098
Cencora
COR
$60.6B
| $76.5M | 0.01% |
925,058
-169,014
| -15% | -$14.3M |
|
1099
TG Therapeutics
TGTX
$7.96B
| $76.5M | 0.01% |
6,451,713
| – | – |
|
1100
National Health Investors
NHI
$3.72B
| $76.4M | 0.01% |
989,000
-527,400
| -35% | -$41.2M |
|
Similar funds
Fidelity Investments's Q3 2017 Portfolio in Review
As of Q3 2017, Fidelity Investments held 2,720 positions worth $827B, up 2.8% from $805B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Fidelity Investments's Q3 2017 filing shows 114 new, 1,012 increased, 1,186 reduced and 130 closed positions. Its largest new stake was Baker Hughes: 18,309,847 shares worth $671M. The largest sale was Du Pont De Nemours E I, an estimated $2.75B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Fidelity Investments's largest Q3 2017 buy was Baker Hughes: 18,309,847 shares worth $671M.
- Fidelity Investments added most to DuPont de Nemours in Q3 2017, an estimated $2.88B increase.
- Fidelity Investments's biggest Q3 2017 reduction was Apple, cutting an estimated $1.81B.
- Fidelity Investments fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $2.75B.
- Fidelity Investments's ten largest holdings make up 18% of its $827B portfolio in Q3 2017.
- Fidelity Investments opened 114 new positions and closed 130 in Q3 2017.
- Fidelity Investments's portfolio value rose 2.8% quarter-over-quarter to $827B.
Based on Fidelity Investments's 13F filing for Q3 2017, filed 13 Nov 2017.